Ameriprise’s Aptose Biosciences, Inc. APTO Stock Holding History

Ameriprise’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-31	Closed	-$37K	–	3786
2019 Q2	$37K	Buy	+31	New	+$28.5K	﹤0.01%	3694

Other funds holding APTO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

PAWC

P.A.W. Capital Greenwich, Connecticut $36.7M AUM 6.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise's APTO Position: Q3 2019 in Review

Ameriprise sold out of Aptose Biosciences, Inc. (APTO) in Q3 2019, closing a stake of 31 shares — an estimated $37K sold.

Ameriprise first reported a position in APTO in Q2 2019 and held it in 1 quarter. The position peaked at $37K in Q2 2019. 31 funds tracked by Wall St. Rank hold APTO as of Q3 2019.

Ameriprise reported no remaining Aptose Biosciences, Inc. position as of Q3 2019 after selling out during the quarter.
Ameriprise sold 31 Aptose Biosciences, Inc. shares in Q3 2019, an estimated $37K.
Ameriprise first reported a position in Aptose Biosciences, Inc. in Q2 2019 and held it in 1 quarter.
Ameriprise's Aptose Biosciences, Inc. position peaked at $37K in Q2 2019.
31 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q3 2019.

Based on Ameriprise's 13F filing for Q3 2019, filed 14 Nov 2019.